Privia Health Group (NASDAQ:PRVA) Given New $38.00 Price Target at Piper Sandler

Privia Health Group (NASDAQ:PRVA) had its target price lifted by Piper Sandler from $36.00 to $38.00 in a research report released on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

PRVA has been the topic of a number of other reports. Canaccord Genuity Group set a $32.00 target price on shares of Privia Health Group in a report on Friday, August 7th. Citigroup reaffirmed a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, September 29th. Finally, Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.25.

Privia Health Group Stock Performance

PRVA stock traded up $0.48 on Friday, reaching $24.42. The company had a trading volume of 2,807,727 shares, compared to its average volume of 1,143,537. The company’s fifty day moving average is $21.04 and its 200 day moving average is $22.64. The company has a market cap of $3.12 billion, a P/E ratio of 93.93 and a beta of 0.76. Privia Health Group has a 1 year low of $18.92 and a 1 year high of $28.82.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.12. Privia Health Group had a return on equity of 3.52% and a net margin of 1.19%. The company had revenue of $656.96 million during the quarter, compared to the consensus estimate of $610.72 million. During the same quarter last year, the business posted $0.29 earnings per share. Privia Health Group’s revenue was up 13.2% compared to the same quarter last year. On average, sell-side analysts predict that Privia Health Group will post 0.27 earnings per share for the current year.

Hedge Funds Weigh In On Privia Health Group

Institutional investors have recently added to or reduced their stakes in the company. Maryland State Retirement & Pension System increased its holdings in shares of Privia Health Group by 64.5% in the 3rd quarter. Maryland State Retirement & Pension System now owns 28,352 shares of the company’s stock valued at $558,000 after acquiring an additional 11,114 shares during the last quarter. Illinois Municipal Retirement Fund increased its position in Privia Health Group by 5.8% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 60,639 shares of the company’s stock valued at $1,194,000 after acquiring an additional 3,316 shares during the period. Parallel Advisors LLC increased its holdings in shares of Privia Health Group by 313.7% during the third quarter. Parallel Advisors LLC now owns 2,180 shares of the company’s stock valued at $43,000 after purchasing an additional 1,653 shares during the period. CenterBook Partners LP bought a new stake in shares of Privia Health Group during the 3rd quarter worth about $1,152,000. Finally, Heritage Family Offices LLP acquired a new stake in Privia Health Group in the third quarter worth approximately $34,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

More Privia Health Group News

Here are the key news stories impacting Privia Health Group this week:

• Positive Sentiment: Privia reported Q3 earnings of $0.21 per share, above the $0.09 consensus estimate, and revenue of $656.96 million versus expectations of $610.72 million. Revenue rose 13.2% year over year. Privia Health Q3 results
• Positive Sentiment: The company raised full-year 2026 guidance across all key financial metrics. Year-to-date adjusted EBITDA was $114.7 million, up 21.9% from the same period in 2025, supporting the improved outlook. Privia Health Q3 results
• Positive Sentiment: Canaccord Genuity raised its price target from $32 to $33 and maintained a Buy rating. Piper Sandler raised its target from $36 to $38 and kept an Overweight rating, signaling increased analyst confidence. Canaccord Genuity price-target update Piper Sandler ratings
• Positive Sentiment: A valuation analysis argued that PRVA could be undervalued following its earnings beat, adding to the positive post-results narrative. Privia Health valuation analysis
• Negative Sentiment: Despite beating estimates, reported quarterly EPS of $0.21 was below the $0.29 reported a year earlier, a potential caveat for investors weighing the strong revenue growth and raised guidance.

About Privia Health Group

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.